188 related articles for article (PubMed ID: 20332435)
1. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
[TBL] [Abstract][Full Text] [Related]
2. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.
Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP
Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774
[TBL] [Abstract][Full Text] [Related]
4. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
[TBL] [Abstract][Full Text] [Related]
5. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.
Yu Y; Kanwar SS; Patel BB; Nautiyal J; Sarkar FH; Majumdar AP
Transl Oncol; 2009 Dec; 2(4):321-8. PubMed ID: 19956394
[TBL] [Abstract][Full Text] [Related]
6. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
[TBL] [Abstract][Full Text] [Related]
7. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
Kanwar SS; Yu Y; Nautiyal J; Patel BB; Padhye S; Sarkar FH; Majumdar AP
Pharm Res; 2011 Apr; 28(4):827-38. PubMed ID: 21161336
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.
Vanamala J; Reddivari L; Radhakrishnan S; Tarver C
BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360
[TBL] [Abstract][Full Text] [Related]
9. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
[TBL] [Abstract][Full Text] [Related]
10. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Codony-Servat J; Cuatrecasas M; Asensio E; Montironi C; Martínez-Cardús A; Marín-Aguilera M; Horndler C; Martínez-Balibrea E; Rubini M; Jares P; Reig O; Victoria I; Gaba L; Martín-Richard M; Alonso V; Escudero P; Fernández-Martos C; Feliu J; Méndez JC; Méndez M; Gallego J; Salud A; Rojo F; Castells A; Prat A; Rosell R; García-Albéniz X; Camps J; Maurel J
Br J Cancer; 2017 Dec; 117(12):1777-1786. PubMed ID: 29123263
[TBL] [Abstract][Full Text] [Related]
11. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation.
Wilsbacher JL; Zhang Q; Tucker LA; Hubbard RD; Sheppard GS; Bamaung NY; Fidanze SD; Wang GT; Hu X; Davidsen SK; Bell RL; Wang J
J Biol Chem; 2008 Aug; 283(35):23721-30. PubMed ID: 18559346
[TBL] [Abstract][Full Text] [Related]
13. IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas.
Wang Q; Zhang Y; Zhu J; Zheng H; Chen S; Chen L; Yang HS
Signal Transduct Target Ther; 2020 Aug; 5(1):153. PubMed ID: 32843616
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
15. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis.
Kaulfuss S; Burfeind P; Gaedcke J; Scharf JG
Mol Cancer Ther; 2009 Apr; 8(4):821-33. PubMed ID: 19372555
[TBL] [Abstract][Full Text] [Related]
16. Curcumin synergizes with resveratrol to inhibit colon cancer.
Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH
Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.
Jones HE; Gee JM; Barrow D; Tonge D; Holloway B; Nicholson RI
Br J Cancer; 2006 Jul; 95(2):172-80. PubMed ID: 16819546
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
Hosseini SA; Zand H; Cheraghpour M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
[No Abstract] [Full Text] [Related]
20. FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
Chen D; Li L; Zhang X; Gao G; Shen L; Hu J; Yang M; Liu B; Qian X
Medicine (Baltimore); 2018 Mar; 97(10):e0097. PubMed ID: 29517682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
